IP Library Granted Patent US 7,910,111
Granted Patent B2
US 7,910,111 · App. 10/553,686 · Granted Mar 22, 2011

Inhibitors of N-ethylmaleimide sensitive factor

Assignee: The Johns Hopkins University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,111
App. No.
10/553,686
Granted
Mar 22, 2011
Kind
B2
Abstract

Methods and compositions for blocking exocytosis by inhibition of proteins that regulate exocytosis, such as N-ethylmaleimide Sensitive Factor (NSF), are provided. The compositions include multidomain fusion peptides containing a domain that causes the fusion peptide to cross the cellular membrane (e.g. a domain from the TAT protein of HIV) and a domain that inhibits NSF (e.g. a domain of NSF). Administration of the fusion peptide promotes anticoagulation, attenuates thrombosis, and decreases heart attack severity.

Claims (4)

1. A fusion peptide comprising,

a first sequence which promotes translocation of said fusion peptide across a membrane, and

a second sequence that inhibits N-ethylmaleimide sensitive factor (NSF) activity, wherein said fusion peptide is SEQ ID NO: 8.

2. The fusion peptide of claim 1 , wherein said membrane is an endothelial cell membrane.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 8, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044394/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2006
From: LOWENSTEIN, CHARLES; MATSUSHITA, KENJI; MORRELL, CRAIG
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 018477/0780 →
Continuity (2)
Provisional Application 60463395 · Apr 15, 2003
Related Publication 20070173441A1 · Jul 26, 2007